Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.0550 (1.93%) ($1.0550 - $1.0550) on Sun. Dec. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.88% (three month average) | RSI | 29 | Latest Price | $1.0550(1.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -2.7% a day on average for past five trading days. | Weekly Trend | ANPC declines -8.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ANPC price | ANPC will decline at least -2.94% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.94% (StdDev 5.88%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-29.62(-2907.58%) | Resistance Level | $1.31 | 5 Day Moving Average | $1.09(-3.21%) | 10 Day Moving Average | $1.15(-8.26%) | 20 Day Moving Average | $1.31(-19.47%) | To recent high | -69.7% | To recent low | 1.9% | Market Cap | $N/A | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |